PATENT CLAIM ANALYSIS

Application Number: 16060301
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-01
Patent Classification: ["424", "133100"]

Abstract:
The invention relates to methods and agents useful for treating motor neuron diseases (MNDs), in particular, amyotrophic lateral sclerosis (ALS). Methods and agents for treating various physiological and pathological conditions associated with motor neuron diseases are also provided.

Claim (Index 11):
The method of  claim 1 , further comprising the administration of riluzole.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 94.0
- Lexical Diversity: 1.35294
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14277825', '14612034', '12570476', '13132923', '13820715']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7043733331222348
- 35 USC 102 Novelty (BERT): 0.5312537235888084
- Combined Prediction Score: 0.6870613721688922
- Mean Citation Score: 295.18081199999995
- Max Citation Score: 301.42636
- Similarity Product: 156.0098396940303

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test